The modification of the tumor microenvironment in HCC is regarded as the trigger for the booster effect of PD-1 or PDL-1 inhibitors, and locoregional therapy has been proven to be an effective means of evoking ICD [33,34]. Here, CD274 is linked to hepatocellular carcinoma.